Japan’s Chugai Pharmaceutical is promising that supply of an orphan drug used to treat acute promyelocytic leukemia will not be interrupted in Japan as it…

Chinese companies now account for more than 50% of the global active pharmaceutical ingredient (API) market. It has more than 500 companies registered to sell…

Impax Laboratories has again been tripped up by labeling issues on a drug and is retrieving a lot of a med for treating epilepsy or bipolar disorders in its…

Recipharm laid out about $160 million to buy Italian CMO Corvette last year and now will plow additional money into one of the three Milan area plants it got…

Sun Pharma continues to slog away at its remediation efforts at both its key plant in Halol as well at the four plants it got in its $4 billion buyout of…

Portola has gotten an FDA CRL largely focused on manufacturing issues for AndexXa, its breakthrough anticoagulant reversal agent. It joins a number of other…

Germany’s Fresenius Kabi will have more sterile injectable production capacity as it invests $250 million to turn a U.S. site into a showcase for its sterile…

Allergan, which this month completed the sale of its Actavis generics unit to Teva, is still cleaning up Actavis business, like the recall of tens of thousands…